Ebstein's anomaly

Common Name(s)

Ebstein's anomaly

Ebstein’s anomaly is a rare heart defect present at birth (congenital). In people with Ebstein’s anomaly, the tricuspid valve, which separates the two right chambers in the heart, is malformed. Normally, the tricuspid valve lets blood flow from the right atrium (upper chamber) to the right ventricle (lower chamber). In Ebstein’s anomaly, the valve is lower than it should be and allows blood to leak back into the atrium. This forces the heart to work harder, and can lead to heart enlargement or failure. Ebstein’s anomaly may be associated with atrial septal defects, heart arrhythmias and Wolff-Parkinson-White syndrome.

Symptoms may include shortness of breath, fatigue, heart palpitations (arrhythmias), or bluish skin or lips (cyanosis). Some people with Ebstein’s abnormality do not develop any severe symptoms, and many will not develop symptoms until later in adulthood. The causes of the anomaly are not yet known, but is believed to be caused by both genetic and environmental factors. People with a family history of heart defects or have heart defects themselves may be more likely to have a baby with Ebstein’s anomaly. A mother’s exposure to medications containing large amounts of lithium or benzodiazepines may also increase the risk for her baby.

Chest X-rays, ultrasounds, MRIs, or EKGs may be performed to diagnose Ebstein’s anomaly. All of these tests will allow a cardiologist to get a clearer picture of the heart. Treatments vary depending on the severity of the anomaly and the symptoms. Treatments can include regular monitoring, medications, surgery, or, in very severe cases, a heart transplant. If you or a loved one has been diagnosed with Ebstein’s anomaly, talk to a cardiologist (a heart doctor) about the most current treatment options. Support organizations and genetic counselors are also good sources of information and can help connect you with others affected by congenital heart conditions.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Ebstein's anomaly" for support, advocacy or research.

Saving Little Hearts

Saving Little Hearts is dedicated to helping children with congenital heart defects and their families by providing emotional assistance and educational information primarily through the distribution of Care Packages.

Last Updated: 15 Mar 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Ebstein's anomaly" for support, advocacy or research.

Saving Little Hearts

Saving Little Hearts is dedicated to helping children with congenital heart defects and their families by providing emotional assistance and educational information primarily through the distribution of Care Packages.

http://www.savinglittlehearts.com

Last Updated: 15 Mar 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Ebstein's anomaly" returned 136 free, full-text research articles on human participants. First 3 results:

Outcomes of Ebstein's Anomaly Patients Treated with Tricuspid Valvuloplasty or Tricuspid Valve Replacement: Experience of a Single Center.
 

Author(s): Bin Li, Han-Song Sun, Shi-Wei Pan, Jian-Ping Xu

Journal: Chin. Med. J.. 2018 May;131(9):1067-1074.

 

The incidence of Ebstein's anomaly is extremely low, and except for the Mayo Clinic, no cardiac center has reported on a sufficient number of patients. The aim of our study was to report the outcomes of Ebstein's anomaly patients treated with tricuspid valvuloplasty (TVP) or tricuspid ...

Last Updated: 31 Dec 1969

Go To URL
Clinical aspects of myocardial fibrosis in adults with Ebstein's anomaly.
 

Author(s): Aleksandra Ciepłucha, Olga Trojnarska, Anna Kociemba, Magdalena Łanocha, Mikolaj Barczynski, Szymon Rozmiarek, Lucyna Kramer, Malgorzata Pyda

Journal: Heart Vessels. 2018 Sep;33(9):1076-1085.

 

Heart failure and arrhythmia are common complications in adults with Ebstein's anomaly. They may result not only from hemodynamic alterations, but also from myocardial fibrosis. Late gadolinium enhancement (LGE) by CMR enables the evaluation of myocardial fibrosis. The aim of the ...

Last Updated: 31 Dec 1969

Go To URL
Recurrent venous thrombosis in a patient with Ebstein's anomaly.
 

Author(s): Deema A Gashgarey, Hazza A Alzahrani, Sultan S Alfadl, Sultan A Alsobayeg

Journal: Saudi Med J. 2018 Feb;39(2):209-212.

 

Herein, we report a case of a 27-year-old man with Ebstein's anomaly and a history of unexplained recurrent venous thrombosis despite adequate anticoagulation. After surgical correction of the Ebstein's anomaly, the venous thromboembolic events did not recur. This case demonstrates ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Ebstein's anomaly" returned 2 free, full-text review articles on human participants. First 3 results:

Ebstein's Anomaly: Genetics, Clinical Manifestations, and Management.
 

Author(s): Shi-Min Yuan

Journal: Pediatr Neonatol. 2017 06;58(3):211-215.

 

Ebstein's anomaly is uncommon. Genetic bases of this congenital heart defect may be related to the mutations in myosin heavy chain 7 and NKX2.5, among others. Asymptomatic patients with Ebstein's anomaly can be conservatively treated and kept under close follow-up, whereas surgical ...

Last Updated: 31 Dec 1969

Go To URL
Electrode catheters and the diagnosis of Ebstein's anomaly of the tricuspid valve.
 

Author(s): H Watson

Journal: Br Heart J. 1966 Mar;28(2):161-71.

 

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Study of Autologous Bone Marrow Derived Mononuclear Cells for Treatment of Ebstein Anomaly
 

Status: Recruiting

Condition Summary: Ebstein Anomaly

 

Last Updated: 5 Oct 2016

Go to URL